OSCIENT PHARMACEUTICALS CORP 4
4 · OSCIENT PHARMACEUTICALS CORP · Filed May 26, 2009
Insider Transaction Report
Form 4
GLG Partners LP
10% Owner
Transactions
- Sale
Common Stock, par value $0.10 ("Common Stock")
2009-05-21$0.30/sh−785,616$236,942→ 73,923 total(indirect: See Footnotes)
Footnotes (2)
- [F1]GLG Partners LP, an English limited partnership, acts as the investment manager for GLG Market Neutral Fund.
- [F2]GLG Partners LP, an English limited partnership, acts as the investment manager of GLG Market Neutral Fund and may be deemed, as of the date hereof, to be the beneficial owner of the Issuer's securities or derivative securities held by GLG Market Neutral Fund. GLG Partners Limited, an English limited company, is the general partner of GLG Partners LP. GLG Partners, Inc. indirectly wholly owns GLG Partners Limited. GLG Partners LP, GLG Partners Limited and GLG Partners, Inc. do not hold directly any of the Issuer's securities or derivative securities with respect thereto, and disclaim any beneficial ownership of any of the Issuer's securities reported or excluded herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended, except for their pecuniary interest therein.